Explore effective diarrhea management strategies, including medication dosing, dietary adjustments, and proactive approaches for better patient outcomes.
Dr. Neil Iyengar, MD
Advertisement
Neil Iyengar, MD, is an associate professor in the Department of Hematology and Medical Oncology and co-director of Breast Medical Oncology in the Department of Hematology and Medical Oncology at Emory University School of Medicine; as well as director of Survivorship Services at the Winship Cancer Institute of Emory University.
Articles by Dr. Neil Iyengar, MD
Learn effective strategies for counseling patients on managing diarrhea when initiating PI3 kinase or AKT pathway inhibitors.
Explore expert insights on managing adverse events in advanced breast cancer treatments targeting the PI3K/AKT/PTEN pathway.
Explore expert insights on managing adverse events in advanced breast cancer treatments targeting the PI3K/AKT/PTEN pathway.
Breast cancer experts discuss adverse effect management when using breast cancer therapies targeting the PI3K, AKT, and mTOR pathways.
Advertisement
Latest Updated Articles
Patient Identification and Molecular Testing in HR+/HER2-Negative Advanced Breast CancerPublished: January 30th 2026 | Updated:
- Baseline Patient Education for Diarrhea Prevention in HR+/HER2-Negative Advanced Breast Cancer
Published: January 30th 2026 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5